BGM Group Ltd. (BGM) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in China, listed on NasdaqCM. Market cap 133.01M USD. 52-week range 6.45 to 303.00 USD. Data as of 2026-10-09.
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. The company operates through Diversified Pharmaceutical and Allied Products; AI Solution; and Insurance Business segments. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical ...